Gian Piero Reverberi

Gian Piero Reverberi

Non-Executive Director

Gian Piero Reverberi was a senior healthcare executive at Ferring Pharmaceuticals, a leader in the areas of reproductive medicine and maternal health, gastroenterology and urology, until April 2026. Prior to this Gian Piero was Senior Vice President and Chief Commercial Officer at Vanda Pharmaceuticals, a specialty pharmaceutical company focused on novel therapies to address high-unmet medical needs. He also spent 10 years at Shire, where he served as Senior Vice President International Specialty Pharma, with responsibility for EMEA, Canada, Asia Pacific and Latin America. He started his pharmaceutical career at Eli Lilly in the US and Italy, where he had responsibilities including finance, business development, sales and business unit leadership.

Importance of contribution

Gian Piero has over 20 years of experience in commercialising novel therapies spanning commercial strategy, business development, business unit leadership and management, launching specialty and orphan drugs across international markets. He has a degree in Economics and Business Administration from Sapienza University of Rome and a Master in Business Administration from SDA Bocconi in Italy.

Date of appointment

1 April 2018

Committee memberships

  • Remuneration Committee (Chair)
  • Audit Committee
  • Nomination and Governance Committee

Current positions

  • None
Other board members
Kemal Malik

Kemal Malik

Senior Independent Director
Julie Cherrington

Julie Cherrington

Non-Executive Director
Norman Crighton

Norman Crighton

Non-Executive Director
John Roche

John Roche

Non-Executive Director